Up-front CART-BCMA With or Without huCART19 in High-risk Multiple Myeloma

NCT03549442 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

COMBINATION_PRODUCT: BCMA CART + huCART19
COMBINATION_PRODUCT: CART BCMA or CART BCMA + huCART19
COMBINATION_PRODUCT: Single-dose infusion of CART BCMA or CART BCMA + huCART19
COMBINATION_PRODUCT: BCMA CART + huCART19

Sponsor

University of Pennsylvania

Collaborators

[object Object]